Wells Fargo raised the firm’s price target on NeuroPace to $16 from $9 and keeps an Equal Weight rating on the shares. The firm is increasing its multiple from 2-times to 4-times given the run up in the stock.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NPCE:
- NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
- NeuroPace Announces Chief Legal Officer Irina Ridley’s Departure
- NeuroPace initiated with an Outperform at Leerink
- Three new option listings on January 24th
- NeuroPace price target raised to $17 from $12 at Lake Street
